ERBB3-related gene PBX1 is associated with prognosis in patients with HER2-positive breast cancer
Abstract Background HER2-positive breast cancer (BC) is a subtype of breast cancer. Increased ERBB3 expression has been implicated as a potential cause of resistance to other HER-targeted therapies. Our study aimed to screen and validate prognostic markers associated with ERBB3 expression by bioinfo...
Saved in:
Main Authors: | Shufen Mo, Haiming Zhong, Weiping Dai, Yuanyuan Li, Bin Qi, Taidong Li, Yongguang Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Genomic Data |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12863-024-01292-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real‐World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)‐Mutant Metastatic Non‐Small Cell Lung Cancer, From a US‐Based Clinico‐Genomic Database
by: Sarah Waliany, et al.
Published: (2024-12-01) -
Identification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer
by: Soo Young Cho
Published: (2019-03-01) -
Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer
by: Taeyeong Kim, et al.
Published: (2025-01-01) -
Ultrafast dynamic contrast-enhanced breast MRI with quantitative perfusion parameters in differentiating breast cancer: a study focusing on triple-negative and HER2 positive breast cancer
by: Guo Haodong, et al.
Published: (2025-01-01) -
Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01)